Blog

A 16-year-old boy with a history of attention-deficit/hyperactivity disorder and epilepsy has received trials of multiple stimulants, but none have adequately controlled his symptoms. His parents therefore would like to switch him to the nonstimulant medication atomoxetine, given its more favorable risk–benefit profile. Which of the following statements correctly describes a U.S. Food and Drug Administration (FDA) bolded warning regarding atomoxetine?

Which of the following is an effective treatment option for dissociative identity disorder (DID)?

What neurotransmitter is primarily synthesized in the Locus Ceruleus and serves as a key player in mediating the sympathetic nervous system, commonly associated with the “Fight or Flight” response?

Which of the following is true regarding sodium oxybate (GHB)?

What medication is commonly used in substance abuse programs for clients experiencing insomnia and anxiety?

What is the primary mechanism of action of Flumazenil in reversing benzodiazepine overdose?

OL is a 34-year-old male with schizophrenia, started on quetiapine 3 months ago with partial response thus far. All appropriate lab work had been performed at that time and was within normal limits. Previous adequate trials of antipsychotics include asenapine, which was ineffective. He is also on lisinopril for hypertension.New lab work/vitals have been obtained. The patient has significant abnormalities in several readings and he has been diagnosed with metabolic syndrome. Which of the following is the most appropriate intervention to make at this time?

Which of the following best describes the monoamine hypothesis of mood disorders?

Which of the following off-label uses of antipsychotics carries a U.S. Food andDrug Administration (FDA) black-box warning for increased mortality risk?

A 40-year-old man with a history of a specific phobia of needles comes to your office seeking treatment. He is due for routine but required blood work in 6 weeks, and he describes significant anticipatory anxiety surrounding the appointment. Which of the following pharmacological options would be most appropriate for this patient?